Kite Pharma (kite) Priced

Biotech developing cancer immunotherapies with the National Cancer Institute.

Health Care - Biotechnology

IPO Performance
Latest Trade $54.66 0.00 (0.0%)
First Day Return 70.6%
Return from IPO 221.5%
 
Kite Pharma IPO News more
  • .
IPO Data
IPO File Date 05/19/2014
Offer Price $17.00
Price Range $15.00 - $16.00
Offer Shares (mm) 7.5
Deal Size ($mm) 128
 
IPO Data
IPO Date 06/19/2014
Offer Price $17.00
Price Range $15.00 - $16.00
Offer Shares (mm) 7.5
Deal Size ($mm) $128
 
Underwriters
more
Business Overview
Biotech developing cancer immunotherapies with the National Cancer Institute.
Biotech developing cancer immunotherapies with the National Cancer Institute.
more
Company Data
Headquarters Santa Monica, CA
Founded 2009
Employees 19
Website www.kitepharma.com
 

Performance vs. IPO Index (IPOUSA)